L-Glutamic gamma-monohydroxamate is an antitumor modified amino acid. It selectively prevents the uptake of L-histidine by microvascular endothelial cells, thereby inhibiting the proliferation of cancer cells. L-Glutamic gamma-monohydroxamate is a vanadium ligand that activates vanadium-induced glucose metabolism and reduces blood glucose levels both in vitro and in vivo.
Molecular Weight:
162.14
Purity:
0.97
CAS Number:
[1955-67-5]
Formula:
C5H10N2O4
Target:
Amino Acids and Derivatives
T81935
* VAT and and shipping costs not included. Errors and price changes excepted
